*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C864 - Blastic NK-cell lymphoma - as a primary diagnosis code | C864 - Blastic NK-cell lymphoma - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 8.66 | |
| Readmission Rate (%) | 52.17 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | |
|---|---|---|---|
| Total Hospitalizations at DRG | 25,646 | ||
| Total Hospitalizations with ICD C864 - Blastic NK-cell lymphoma | 24 | ||
| DRG Share of Total Hospitalizations | 0.08 | ||
| % of Total ICD C864 - Blastic NK-cell lymphoma in DRG | 36.36 | ||
| Avg LOS at DRG | 5.67 | ||
| Avg LOS with ICD C864 - Blastic NK-cell lymphoma | 8.13 | ||
| Readmission Rate at DRG | 36.28 | ||
| Readmission Rate with ICD C864 - Blastic NK-cell lymphoma | 63.64 | ||
| Unplanned Readmission Rate at DRG | 22.95 | ||
| Unplanned Readmission Rate with ICD C864 - Blastic NK-cell lymphoma | NA | ||
| Total Medicare payments at DRG | $299,718,477 | ||
| Total Medicare payments with ICD C864 - Blastic NK-cell lymphoma | $508,749 | ||
| Total Medicare payment per Day at DRG | $2,062 | ||
| Total Medicare payment per Day with ICD C864 - Blastic NK-cell lymphoma | $2,609 | ||
| Total Medicare payment per Hospitalization at DRG | $11,687 | ||
| Total Medicare payment per Hospitalization with ICD C864 - Blastic NK-cell lymphoma | $21,198 | ||
| Total Medicare Charges at DRG | $1,432,739,779 | ||
| Total Medicare Charges with ICD C864 - Blastic NK-cell lymphoma | $2,003,354 | ||
| Avg Charges at DRG | $55,866 | ||
| Avg Charges with ICD C864 - Blastic NK-cell lymphoma | $83,473 | ||
| Mortality Rate at DRG | 2.6 | ||
| Mortality Rate with ICD C864 - Blastic NK-cell lymphoma | NA | ||
| SNF Discharge Rate at DRG | 13.23 | ||
| SNF Discharge Rate with ICD C864 - Blastic NK-cell lymphoma | NA | ||
| Home Discharge Rate at DRG | 49.84 | ||
| Home Discharge Rate with ICD C864 - Blastic NK-cell lymphoma | 62.5 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 45,065 | ||||
| Total Hospitalizations with ICD C864 - Blastic NK-cell lymphoma | 114 | ||||
| DRG Share of Total Hospitalizations | 0.14 | ||||
| % of Total ICD C864 - Blastic NK-cell lymphoma in DRG | 32.2 | ||||
| Avg LOS at DRG | 4.03 | ||||
| Avg LOS with ICD C864 - Blastic NK-cell lymphoma | 5.14 | ||||
| Readmission Rate at DRG | 66.75 | ||||
| Readmission Rate with ICD C864 - Blastic NK-cell lymphoma | 70.54 | ||||
| Unplanned Readmission Rate at DRG | 10.94 | ||||
| Unplanned Readmission Rate with ICD C864 - Blastic NK-cell lymphoma | NA | ||||
| Total Medicare payments at DRG | $438,494,977 | ||||
| Total Medicare payments with ICD C864 - Blastic NK-cell lymphoma | $1,592,447 | ||||
| Total Medicare payment per Day at DRG | $2,416 | ||||
| Total Medicare payment per Day with ICD C864 - Blastic NK-cell lymphoma | $2,717 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,730 | ||||
| Total Medicare payment per Hospitalization with ICD C864 - Blastic NK-cell lymphoma | $13,969 | ||||
| Total Medicare Charges at DRG | $2,145,591,374 | ||||
| Total Medicare Charges with ICD C864 - Blastic NK-cell lymphoma | $4,101,575 | ||||
| Avg Charges at DRG | $47,611 | ||||
| Avg Charges with ICD C864 - Blastic NK-cell lymphoma | $35,979 | ||||
| Mortality Rate at DRG | 0.08 | ||||
| Mortality Rate with ICD C864 - Blastic NK-cell lymphoma | NA | ||||
| SNF Discharge Rate at DRG | 4.35 | ||||
| SNF Discharge Rate with ICD C864 - Blastic NK-cell lymphoma | NA | ||||
| Home Discharge Rate at DRG | 81.76 | ||||
| Home Discharge Rate with ICD C864 - Blastic NK-cell lymphoma | 91.23 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | |
|---|---|
| Total Hospitalizations at DRG | 3,410 |
| Total Hospitalizations with ICD C864 - Blastic NK-cell lymphoma | 11 |
| DRG Share of Total Hospitalizations | 0.01 |
| % of Total ICD C864 - Blastic NK-cell lymphoma in DRG | 3.11 |
| Avg LOS at DRG | 27.15 |
| Avg LOS with ICD C864 - Blastic NK-cell lymphoma | 26.36 |
| Readmission Rate at DRG | 28.76 |
| Readmission Rate with ICD C864 - Blastic NK-cell lymphoma | NA |
| Unplanned Readmission Rate at DRG | 8.51 |
| Unplanned Readmission Rate with ICD C864 - Blastic NK-cell lymphoma | NA |
| Total Medicare payments at DRG | $316,670,719 |
| Total Medicare payments with ICD C864 - Blastic NK-cell lymphoma | $1,091,215 |
| Total Medicare payment per Day at DRG | $3,421 |
| Total Medicare payment per Day with ICD C864 - Blastic NK-cell lymphoma | $3,763 |
| Total Medicare payment per Hospitalization at DRG | $92,865 |
| Total Medicare payment per Hospitalization with ICD C864 - Blastic NK-cell lymphoma | $99,201 |
| Total Medicare Charges at DRG | $1,488,215,147 |
| Total Medicare Charges with ICD C864 - Blastic NK-cell lymphoma | $4,186,938 |
| Avg Charges at DRG | $436,427 |
| Avg Charges with ICD C864 - Blastic NK-cell lymphoma | $380,631 |
| Mortality Rate at DRG | 4.96 |
| Mortality Rate with ICD C864 - Blastic NK-cell lymphoma | NA |
| SNF Discharge Rate at DRG | 0.88 |
| SNF Discharge Rate with ICD C864 - Blastic NK-cell lymphoma | NA |
| Home Discharge Rate at DRG | 65.84 |
| Home Discharge Rate with ICD C864 - Blastic NK-cell lymphoma | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MOFFITT CANCER CENTER | 12902 MAGNOLIA DR | TAMPA | FL | 33612 | 48 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 43 |
| CITY OF HOPE DUARTE | 1500 E DUARTE RD | DUARTE | CA | 91010 | 30 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. LUBOMIR SOKOL | 12902 USF MAGNOLIA DR | TAMPA | FL | 33612 | 15 |